Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Selectins01:25

Selectins

4.8K
Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.8K
Gallbladder01:17

Gallbladder

3.0K
The gallbladder is a small, pear-shaped organ that plays a crucial role in our digestive system. Measuring about 10 cm in length, it is comparable in size to a kiwi fruit and is located in a hollow area on the lower surface of the liver. The gallbladder's primary function is to store and concentrate bile, a fluid produced by the liver that aids in digestion.
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Copper-deficiency anemia and neutropenia during zinc maintenance therapy for Wilson disease associated with persistent strict dietary copper restriction.

Clinical journal of gastroenterology·2026
Same author

Real-World Comparison of First-Line Atezolizumab plus Bevacizumab and Durvalumab plus Tremelimumab for Unresectable Hepatocellular Carcinoma.

Liver cancer·2026
Same author

Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.

Journal of gastroenterology and hepatology·2026
Same author

Widespread Muscle Loss in Autoimmune Hepatitis and Its Adverse Prognostic Impact.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same author

Optimizing bevacizumab exposure in atezolizumab-based therapy for unresectable hepatocellular carcinoma: A nationwide real-world study.

Hepatology (Baltimore, Md.)·2026
Same author

Evaluation of Factors Affecting Alpha Fetoprotein Levels in Patients With Hepatocellular Carcinoma in a Large Multicenter Cohort.

Journal of gastroenterology and hepatology·2026

Related Experiment Video

Updated: Mar 26, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

9.3K

Galectin-9: An anticancer molecule for gallbladder carcinoma.

Tomoko Tadokoro1, Asahiro Morishita1, Shintaro Fujihara1

  • 1Department of Gastroenterology and Neurology, Kagawa University, Kagawa, Japan.

International Journal of Oncology
|January 23, 2016
PubMed
Summary

Galectin-9 (Gal-9) shows promise in treating gallbladder cancer (GBC). This study found Gal-9 suppresses GBC cell growth and tumor development by inducing apoptosis and altering microRNA expression.

More Related Videos

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

4.9K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K

Related Experiment Videos

Last Updated: Mar 26, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

9.3K
Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

4.9K
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.4K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Gallbladder cancer (GBC) is an aggressive biliary tract cancer, with adenocarcinomas being the most common type.
  • Rare subtypes like squamous and adenosquamous carcinomas exhibit poorer prognoses.
  • Galectin-9 (Gal-9) is known to induce apoptosis in various cancer types.

Purpose of the Study:

  • To investigate the potential antitumor effects of Galectin-9 (Gal-9) on gallbladder cancer (GBC).
  • To explore the mechanisms underlying Gal-9's action in GBC, including apoptosis induction and molecular pathway alterations.

Main Methods:

  • In vitro studies using GBC cell lines to assess Gal-9's effect on proliferation and apoptosis.
  • In vivo xenograft models with implanted human GBC cells to evaluate tumor growth suppression.
  • Analysis of key molecular markers including caspase-cleaved keratin 18, phosphorylated p53, Ephrin type-B receptor, and microRNA (miRNA) expression profiles.

Main Results:

  • Gal-9 suppressed proliferation in most GBC cell lines, except for a poorly differentiated adenosquamous carcinoma line.
  • Gal-9 induced apoptosis in sensitive GBC cells via increased caspase-cleaved keratin 18 and phosphorylated p53.
  • In vivo, Gal-9 inhibited tumor growth in a xenograft model and altered miRNA expression profiles.

Conclusions:

  • Galectin-9 demonstrates significant antitumor activity against gallbladder cancer.
  • Apoptosis induction and modulation of miRNA expression are key mechanisms of Gal-9's efficacy.
  • Gal-9 presents a potential therapeutic candidate for gallbladder cancer treatment.